Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

A perspective on "cure" for Rett syndrome

Clarke, Angus John ORCID: https://orcid.org/0000-0002-1200-9286 and Abdala Sheikh, Ana Paula 2018. A perspective on "cure" for Rett syndrome. Orphanet Journal of Rare Diseases 13 (1) , 44. 10.1186/s13023-018-0786-6

[thumbnail of Clarke & Abdala 2018 OJRD A perspective on cure for Rett syndrome.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (347kB) | Preview

Abstract

The reversal of the Rett syndrome disease process in the Mecp2 mouse model of Guy et al. (2007) has motivated families and researchers to work on this condition. The reversibility in adult mice suggests that there is potentially much to be gained from rational treatments applied to patients of any age. However, it may be difficult to strike the right balance between enthusiasm on the one hand and realism on the other. One effect of this has been a fragmentation of the “Rett syndrome community” with some groups giving priority to work aimed at a cure while fewer resources are devoted to medical or therapy-based interventions to enhance the quality of life of affected patients or provide support for their families. Several possible therapeutic approaches are under development that, it is claimed and hoped, may lead to a “cure” for patients with Rett syndrome. While all have a rationale, there are potential obstacles to each being both safe and effective. Furthermore, any strategy that succeeded in restoring normal levels of MECP2 gene expression throughout the brain carries potential pitfalls, so that it will be of crucial importance to introduce any clinical trials of such therapies with great care. Expectations of families for a radical, rational treatment should not be inflated beyond a cautious optimism. This is particularly because affected patients with us now may not be able to reap the full benefits of a “cure”. Thus, interventions aimed at enhancing the quality of life of affected patients should not be forgone and their importance should not be minimised.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: BioMed Central
ISSN: 1750-1172
Date of First Compliant Deposit: 20 April 2018
Date of Acceptance: 16 March 2018
Last Modified: 06 May 2023 21:26
URI: https://orca.cardiff.ac.uk/id/eprint/110826

Citation Data

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics